Multi-omics analysis reveals CXCL14+ inhibitory neuron dysfunction in major depressive disorder
Journal of Affective Disorders · 2026-07 · 405 · 121586
DOI: 10.1016/j.jad.2026.121586 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Affective Disorders, 2026-07. Verfasst von Lingfeng Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Renmin Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Major Depressive Disorder, Chemokines, CXC, Neurons, Dorsolateral Prefrontal Cortex. Die Arbeit nennt 51 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Major Depressive Disorder (MDD) is a complex psychiatric condition characterized by neuronal and functional disruptions in the dorsolateral prefrontal cortex (dlPFC). We integrated two single-nucleus RNA sequencing (snRNA-seq) datasets, GWAS summary data, and proteomic data from UK Biobank. We identified 273 MDD-associated expression quantitative trait loci (eQTL), while the single-cell disease-relevance score (scDRS) algorithm revealed that excitatory neurons, inhibitory neurons, and oligodendrocyte precursor cells (OPCs) are significantly associated with MDD. Non-negative matrix factorization (NMF) identified four meta-programs in neurons, reflecting functional impairments related to synaptic plasticity, neuronal connectivity, and epigenetic regulation. We characterized distinct pathological states of neuronal subtypes and identified CXCL14+ inhibitory neurons' role in stress perception. Plasma proteomic analyses provided independent peripheral support for five MDD associated risk genes whose encoded proteins showed prognostic value in CoxBoost models. Chronic unpredictable mild stress (CUMS) and chronic restraint stress (CRS) mouse models supported stress-induced alterations in prefrontal Cxcl14 expression. These findings provide a comprehensive understanding of MDD from a multi-omics perspective, offering potential diagnostic and therapeutic targets for MDD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, Renmin Hospital of Wuhan University, Wuhan, China.
- Department of Dermatology, The Third Affiliated Hospital of Sun Yat-Sen University, 600 Tianhe Road, Guangzhou, China.
- Department of Psychiatry, Renmin Hospital of Wuhan University, Wuhan, China; Department of Psychiatry, School of Clinical Medicine, University of Cambridge, United Kingdom.
- Department of Psychiatry, Renmin Hospital of Wuhan University, Wuhan, China; Taikang Center for Life and Medical Sciences, Wuhan University, Wuhan, China; State Key Laboratory of Metabolism and Regulation in Complex Org…
Förderung
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Key Technologies Research and Development Program
Zitieren
APA
Zhang, L., Duan, H., Lyu, H., Ma, S., Xu, Y., Xie, X., Gong, Q., Kang, L., Chen, S., & Liu, Z. (2026). Multi-omics analysis reveals CXCL14+ inhibitory neuron dysfunction in major depressive disorder. Journal of Affective Disorders, 405, 121586. https://doi.org/10.1016/j.jad.2026.121586
Vancouver
Zhang L, Duan H, Lyu H, Ma S, Xu Y, Xie X, et al. Multi-omics analysis reveals CXCL14+ inhibitory neuron dysfunction in major depressive disorder. Journal of Affective Disorders. 2026;405:121586. doi:10.1016/j.jad.2026.121586
BibTeX
@article{Zhang2026,
author = {Zhang, Lingfeng and Duan, Hao and Lyu, Honggang and Ma, Simeng and Xu, Yantao and Xie, Xinhui and Gong, Qian and Kang, Lijun and Chen, Shijia and Liu, Zhongchun},
title = {Multi-omics analysis reveals CXCL14+ inhibitory neuron dysfunction in major depressive disorder},
journal = {Journal of Affective Disorders},
year = {2026},
volume = {405},
pages = {121586},
doi = {10.1016/j.jad.2026.121586}
}
EUVIMED